Nektar Therapeutics (NKTR)

11:54 AM

Why retail investors pile into Nektar Therapeutics stockWeekly Investment Report & Verified Stock Trade Ideas - newser.com

11:54 AM

11:18 AM

Is Nektar Therapeutics stock a good choice for value investorsGap Up & Verified Entry Point Signals - newser.com

11:18 AM

11:00 AM

Best data tools to analyze Nektar Therapeutics stockJuly 2025 Breakouts & Precise Trade Entry Recommendations - newser.com

11:00 AM

10:30 AM

Using economic indicators to assess Nektar Therapeutics potentialJuly 2025 Earnings & AI Enhanced Market Trend Forecasts - newser.com

10:30 AM

08:57 AM

This Stock Is Up By 285% This Year But Could Still Jump By 53%, According to Wall Street - The Globe and Mail

08:57 AM

05:28 AM

Will Nektar Therapeutics stock benefit from AI adoptionEarnings Risk Report & AI Forecast Swing Trade Picks - newser.com

05:28 AM

Oct 12, 2025

Custom strategy builders for tracking Nektar TherapeuticsVolume Spike & Expert Curated Trade Setups - newser.com

Oct 12, 2025

Oct 12, 2025

Quantitative breakdown of Nektar Therapeutics recent moveQuarterly Portfolio Report & High Accuracy Trade Signal Alerts - newser.com

Oct 12, 2025

Oct 12, 2025

Here's Why Nektar Therapeutics Stock Rocketed 90.6% Higher in September - MSN

Oct 12, 2025

Oct 11, 2025

Wealth Enhancement Advisory Services LLC Reduces Stake in Nektar Therapeutics $NKTR - MarketBeat

Oct 11, 2025

Oct 10, 2025

Why Nektar Therapeutics Stock Zoomed More Than 15% Higher Today - MSN

Oct 10, 2025

Oct 10, 2025

Nektar Therapeutics' (NKTR) "Sell (D-)" Rating Reiterated at Weiss Ratings - MarketBeat

Oct 10, 2025

Oct 10, 2025

What MACD and RSI say about Nektar TherapeuticsJuly 2025 Fed Impact & Smart Money Movement Tracker - newser.com

Oct 10, 2025

Oct 10, 2025

Evaluating Nektar Therapeutics with trendline analysisJuly 2025 Breakouts & Free Reliable Trade Execution Plans - newser.com

Oct 10, 2025

Oct 09, 2025

Moderate to Severe Atopic Dermatitis Pipeline Drugs Insights Report 2025: Emerging Therapies, Clinical Developments, and Drug Insights by DelveInsight - The Globe and Mail

Oct 09, 2025

Oct 09, 2025

How Nektar Therapeutics (ITH0) stock responds to job market shiftsNew Guidance & Reliable Price Breakout Alerts - newser.com

Oct 09, 2025

Oct 09, 2025

Sector ETF performance correlation with Nektar Therapeutics2025 Technical Patterns & AI Driven Price Predictions - newser.com

Oct 09, 2025

Oct 08, 2025

Gainplan LLC Buys New Shares in Nektar Therapeutics $NKTR - MarketBeat

Oct 08, 2025

Oct 08, 2025

Public Employees Retirement System of Ohio Sells 121,001 Shares of Nektar Therapeutics $NKTR - MarketBeat

Oct 08, 2025

Oct 07, 2025

Nektar Therapeutics (NKTR): Examining Valuation After Breakthrough Eczema Drug Trial Results Spark Investor Interest - Sahm

Oct 07, 2025

Oct 06, 2025

How Nektar Therapeutics (ITH0) stock reacts to weak economyDividend Hike & Real-Time Stock Movement Alerts - newser.com

Oct 06, 2025

Oct 05, 2025

What analysts say about Nektar Therapeutics stockSwing Trading Watchlist & Build Wealth With Expert Timing Advice - earlytimes.in

Oct 05, 2025

Oct 05, 2025

Real time social sentiment graph for Nektar TherapeuticsTrade Entry Report & Fast Exit and Entry Strategy Plans - newser.com

Oct 05, 2025

Oct 05, 2025

Is a relief rally coming for Nektar Therapeutics holdersTrade Entry Summary & Advanced Swing Trade Entry Plans - newser.com

Oct 05, 2025

Oct 03, 2025

How analysts rate Nektar Therapeutics stock today2025 Support & Resistance & Long-Term Safe Return Strategies - newser.com

Oct 03, 2025

Oct 03, 2025

Why Nektar Therapeutics (NKTR) Is Up 8.8% After Positive Phase 2b Rezpegaldesleukin Data at EADV - simplywall.st

Oct 03, 2025

Oct 02, 2025

Nektar Therapeutics (NASDAQ:NKTR) Reaches New 52-Week HighTime to Buy? - MarketBeat

Oct 02, 2025

Oct 02, 2025

Nektar Therapeutics stock hits 52-week high at 61.24 USD By Investing.com - Investing.com South Africa

Oct 02, 2025

Oct 02, 2025

Nektar Therapeutics stock hits 52-week high at 61.24 USD - Investing.com

Oct 02, 2025

Oct 02, 2025

The biotech scorecard for the fourth quarter: 36 stock-moving events to watch - statnews.com

Oct 02, 2025

Oct 02, 2025

BTIG Maintains Nektar Therapeutics(NKTR.US) With Buy Rating, Maintains Target Price $100 - 富途牛牛

Oct 02, 2025

Oct 01, 2025

Building trade automation scripts for Nektar TherapeuticsJuly 2025 PostEarnings & Community Trade Idea Sharing Platform - newser.com

Oct 01, 2025

Oct 01, 2025

Voya Investment Management LLC Raises Stock Holdings in Nektar Therapeutics $NKTR - MarketBeat

Oct 01, 2025